IRIS

Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy / Jacques, Sk; Mckeown, J; Grover, P; Johnson, Db; Zaremba, A; Dimitriou, F; Weiser, R; Farid, M; Namikawa, K; Sullivan, Rj; Rutkowski, P; Lebbe, C; Hamid, O; Zager, Js; Michielin, O; Neyns, B; Nakamura, Y; Robert, C; Mehnert, J; Ascierto, Pa; Bhave, P; Park, B; Zimmer, L; Mangana, J; Mooradian, M; Placzke, J; Allayous, C; Glitza Oliva, Ic; Mehmi, I; Depalo, D; Wicky, A; Schwarze, Jk; Roy, S; Boatwright, C; Vanella, V; Long, Gv; Menzies, Am; Lo, Sn; Carlino, Ms. - In: EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. - ISSN 0277-5379. - (2024). [10.1016/j.ejca.2024.113563]

Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy

Johnson DB;Ascierto PA;
2024
2024
Outcomes of patients with resected stage III/IV acral or mucosal melanoma, treated with adjuvant anti-PD-1 based therapy / Jacques, Sk; Mckeown, J; Grover, P; Johnson, Db; Zaremba, A; Dimitriou, F; Weiser, R; Farid, M; Namikawa, K; Sullivan, Rj; Rutkowski, P; Lebbe, C; Hamid, O; Zager, Js; Michielin, O; Neyns, B; Nakamura, Y; Robert, C; Mehnert, J; Ascierto, Pa; Bhave, P; Park, B; Zimmer, L; Mangana, J; Mooradian, M; Placzke, J; Allayous, C; Glitza Oliva, Ic; Mehmi, I; Depalo, D; Wicky, A; Schwarze, Jk; Roy, S; Boatwright, C; Vanella, V; Long, Gv; Menzies, Am; Lo, Sn; Carlino, Ms. - In: EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY. - ISSN 0277-5379. - (2024). [10.1016/j.ejca.2024.113563]
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1017390
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 17
  • ???jsp.display-item.citation.isi??? 16
social impact